These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 22104249)

  • 1. Neck dissection field and lymph node density predict prognosis in patients with oral cavity cancer and pathological node metastases treated with adjuvant therapy.
    Liao CT; Hsueh C; Lee LY; Lin CY; Fan KH; Wang HM; Huang SF; Chen IH; Kang CJ; Ng SH; Tsao CK; Huang YC; Yen TC
    Oral Oncol; 2012 Apr; 48(4):329-36. PubMed ID: 22104249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical nodal stage is a significant predictor of outcome in patients with oral cavity squamous cell carcinoma and pathologically negative neck metastases: results of the international consortium for outcome research.
    Amit M; Yen TC; Liao CT; Binenbaum Y; Chaturvedi P; Agarwal JP; Kowalski LP; Ebrahimi A; Clark JR; Cernea CR; Brandao SJ; Kreppel M; Zöller J; Fliss D; Bachar G; Shpitzer T; Bolzoni VA; Patel PR; Jonnalagadda S; Robbins KT; Shah JP; Patel SG; Gil Z;
    Ann Surg Oncol; 2013 Oct; 20(11):3575-81. PubMed ID: 23775408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of lymph node density in node-positive patients with oral squamous cell carcinoma.
    Kim SY; Nam SY; Choi SH; Cho KJ; Roh JL
    Ann Surg Oncol; 2011 Aug; 18(8):2310-7. PubMed ID: 21336511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The number of pathologically positive lymph nodes and pathological tumor depth predicts prognosis in patients with poorly differentiated squamous cell carcinoma of the oral cavity.
    Kang CJ; Lin CY; Wang HM; Fan KH; Ng SH; Lee LY; Chen IH; Huang SF; Liao CT; Yen TC
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e223-30. PubMed ID: 21640500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome analysis of patients with oral cavity cancer and extracapsular spread in neck lymph nodes.
    Liao CT; Lee LY; Huang SF; Chen IH; Kang CJ; Lin CY; Fan KH; Wang HM; Ng SH; Yen TC
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):930-7. PubMed ID: 20934267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can metastatic lymph node ratio (LNR) predict survival in oral cavity cancer patients?
    Sayed SI; Sharma S; Rane P; Vaishampayan S; Talole S; Chaturvedi P; Chaukar D; Deshmukh A; Agarwal JP; D'cruz AK
    J Surg Oncol; 2013 Sep; 108(4):256-63. PubMed ID: 23893514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome analyses of unusual site neck recurrence in oral cavity cancer.
    Liao CT; Lin CY; Fan KH; Hsueh C; Lee LY; Wang HM; Huang SF; Chen IH; Kang CJ; Ng SH; Lin CH; Huang YC; Yen TC
    Ann Surg Oncol; 2013 Jan; 20(1):257-66. PubMed ID: 22872292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome analysis of patients with well-differentiated oral cavity squamous cell carcinoma.
    Kang CJ; Liao CT; Hsueh C; Lee LY; Lin CY; Fan KH; Wang HM; Huang SF; Chen IH; Ng SH; Tsao CK; Huang YC; Yen TC
    Oral Oncol; 2011 Nov; 47(11):1085-91. PubMed ID: 21840751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node density is a significant predictor of outcome in patients with oral cancer.
    Gil Z; Carlson DL; Boyle JO; Kraus DH; Shah JP; Shaha AR; Singh B; Wong RJ; Patel SG
    Cancer; 2009 Dec; 115(24):5700-10. PubMed ID: 19691095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter Retrospective Study of Adjuvant Therapy for Patients with Pathologically Lymph Node-Positive Oral Squamous Cell Carcinoma: Analysis of Covariance Using Propensity Score.
    Yanamoto S; Otsuru M; Ota Y; Okura M; Aikawa T; Kurita H; Kamata T; Kirita T; Yamakawa N; Ueda M; Yamashita T; Komori T; Shigeta T; Yokoo S; Ogawa M; Umeda M;
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S992-9. PubMed ID: 26289809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of postoperative chemotherapy and radiotherapy on patients with squamous cell carcinoma of the oral cavity and multiple regional lymph node metastases.
    Takahashi H; Yanamoto S; Yamada S; Umeda M; Shigeta T; Minamikawa T; Shibuya Y; Komori T; Shiraishi T; Asahina I; Yokoo S; Ri S
    Int J Oral Maxillofac Surg; 2014 Jun; 43(6):680-5. PubMed ID: 24387949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total lesion glycolysis: a possible new prognostic parameter in oral cavity squamous cell carcinoma.
    Abd El-Hafez YG; Moustafa HM; Khalil HF; Liao CT; Yen TC
    Oral Oncol; 2013 Mar; 49(3):261-8. PubMed ID: 23036774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node ratio as an independent prognostic factor in oral squamous cell carcinoma.
    Ebrahimi A; Clark JR; Zhang WJ; Elliott MS; Gao K; Milross CG; Shannon KF
    Head Neck; 2011 Sep; 33(9):1245-51. PubMed ID: 20967874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
    Layland MK; Sessions DG; Lenox J
    Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of patients with clinically lymph node-negative squamous cell carcinoma of the oral cavity.
    Jang WI; Wu HG; Park CI; Kim KH; Sung MW; Kim MJ; Choung PH; Lee JH; Choi JY
    Jpn J Clin Oncol; 2008 Jun; 38(6):395-401. PubMed ID: 18573849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elective neck dissection for carcinomas of the oral cavity: occult metastases, neck recurrences, and adjuvant treatment of pathologically positive necks.
    Zbären P; Nuyens M; Caversaccio M; Stauffer E
    Am J Surg; 2006 Jun; 191(6):756-60. PubMed ID: 16720144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative [18F]fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes predicts neck cancer control and survival rates in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes.
    Liao CT; Chang JT; Wang HM; Ng SH; Hsueh C; Lee LY; Lin CH; Chen IH; Huang SF; Cheng AJ; Yen TC
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1054-61. PubMed ID: 19101096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of selective neck dissection (I-III) in the treatment of node negative (N0) neck in oral cancer.
    Iype EM; Sebastian P; Mathew A; Balagopal PG; Varghese BT; Thomas S
    Oral Oncol; 2008 Dec; 44(12):1134-8. PubMed ID: 18486527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical lymph node dissection for clinically submucosal carcinoma of the thoracic esophagus.
    Kosugi S; Kawaguchi Y; Kanda T; Ishikawa T; Sakamoto K; Akaike H; Fujii H; Wakai T
    Ann Surg Oncol; 2013 Nov; 20(12):4016-21. PubMed ID: 23892526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognosis of N2b and N2c lymph node disease in oral squamous cell carcinoma is determined by the number of metastatic lymph nodes rather than laterality: evidence to support a revision of the American Joint Committee on Cancer staging system.
    Ebrahimi A; Gil Z; Amit M; Yen TC; Liao CT; Chaturvedi P; Agarwal JP; Kowalski LP; Kohler HF; Kreppel M; Cernea CR; Brandao J; Bachar G; Bolzoni Villaret A; Fliss D; Fridman E; Robbins KT; Shah JP; Patel SG; Clark JR;
    Cancer; 2014 Jul; 120(13):1968-74. PubMed ID: 24691658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.